Plain-English translation of NCT06746194 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether a special imaging scan called 68Ga-FAPI PET/CT can help doctors better understand how well cancer treatment is working in people with advanced hepatocellular carcinoma (liver cancer). This scan takes pictures of your body to show where cancer cells are active. The study will compare what the scan shows with tissue samples to see if the scan is accurate.
Current methods of checking whether liver cancer treatment is working don't always give doctors clear answers. This new imaging approach may help doctors see more clearly which treatments are actually shrinking the cancer, so they can make better decisions about your care.
You likely qualify if…
You likely don't qualify if…
You will have a special imaging scan called 68Ga-FAPI PET/CT before your cancer treatment begins. Then you will receive your regular cancer treatment as planned. After 3 months of treatment, you will have the same imaging scan again. The research team will compare the two scans to see how well your treatment is working and will collect some basic information about you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China
Sponsor
Ruijin Hospital
Enrollment target
~40 participants
Started
December 2024
Primary completion
December 2028
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiajia Hu
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.